| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60e66be87630d7cef0ce770e1d898eec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1d0e0bf0c82b5815b03ec1788ddf2c9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202 |
| filingDate |
2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfeff85cdba63027552304c6da634212
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_066175ed5cfea7be262033fc1e40a2ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c1370f3692584fc815fdd97e0dc25c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e836616906e56371d000bd717263768c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c952a26eb74fe810771501cae4de94a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c15e0b1ff4ab46040f73e8f1c5fc15e7 |
| publicationDate |
2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018110748-A1 |
| titleOfInvention |
Composition for reducing or suppressing increase in neutral fat level containing n-3 unsaturated fatty acid, and use of n-3 unsaturated fatty acid in production of same composition |
| abstract |
A composition which can efficiently obtain an effect of decreasing or suppressing an increase in the neutral fat level is provided. n Docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA) is used as an active ingredient of a composition for decreasing or suppressing an increase in the neutral fat level, and the timing of intake of the active ingredient is within a time for intake within 6 hours after arousal from sleep including the breakfast time essentially including the breakfast time. |
| priorityDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |